Dehydroepiandrosterone decreases vaginal atrophy in humans.
“local daily intravaginal DHEA administration at DHEA doses of 3.25-13 mg was able to rapidly and efficiently achieve correction of all the signs and symptoms of vaginal atrophy”
Dehydroepiandrosterone decreases vaginal atrophy in postmenopausal estrogen-deficient women.
“vaginally administered DHEA may improve vaginal atrophy with concomitant improvements in sexual function in women who are estrogen deficient due to menopause.”
Phoenix dactylifera decreases vaginal atrophy in humans (climacteric and menopause).
“dates (Phoenix dactylifera L.) emerge as an accessible nutritional alternative rich in minerals and phytoestrogens, helping to combat vaginal atrophy and dryness.”
Cell-free fat extract decreases vaginal atrophy in ovariectomized mice.
“CEFFE-treated mice showed increased mucosal thickness and number of vaginal mucosal cell layers and reduced vaginal atrophy compared to ovariectomized mice.”
Punica granatum is associated with vaginal atrophy in mice following ovariectomy.
“In a pre-clinical murine model following ovariectomy, improved bone formation and reduced vaginal atrophy were associated with pomegranate treatment.”
In a prospective study of postmenopausal women, 12 weeks of vaginal estrogen shifted urinary bacterial communities towards those seen in women without tissue thinning or…In a prospective study of postmenopausal women, 12 weeks of vaginal estrogen shifted urinary bacterial communities towards those seen in women without tissue thinning or symptoms.
Adjusted sexual quality of life scores were 7.7 points higher with nettle cream than with placebo after eight weeks of treatment.Adjusted sexual quality of life scores were 7.7 points higher with nettle cream than with placebo after eight weeks of treatment.